Are the following hormone and insulin results—follicle‑stimulating hormone 3.2 IU/L, luteinizing hormone 4.6 IU/L, prolactin (value not provided), estradiol 272 pmol/L, progesterone 1.5 nmol/L, testosterone 2.4 nmol/L, insulin 33 U/mL—compatible with a diagnosis of polycystic ovary syndrome (PCOS)?

Hormonal Profile Assessment for PCOS Diagnosis

These results show several features compatible with PCOS, but the diagnosis cannot be confirmed by hormones alone—you must also assess clinical features (menstrual irregularity, hyperandrogenism signs) and consider pelvic ultrasound or AMH levels to meet diagnostic criteria.

Analysis of the Provided Hormone Values

LH/FSH Ratio

• Your patient's ratio: 1.44 (LH 4.6 ÷ FSH 3.2)
• The LH/FSH ratio of 1.44 falls below the classic threshold of >2 that guidelines associate with PCOS 11
• However, recent evidence shows this ratio is not required for diagnosis—only 18% of confirmed PCOS patients have LH/FSH >2 2
• The ratio >1.23 still has diagnostic value (sensitivity 75-93%, specificity 83-93%) 3
• Your patient's ratio of 1.44 exceeds this lower threshold, suggesting possible PCOS, particularly the non-hyperandrogenic phenotype D 2

Testosterone Level

• Your patient's value: 2.4 nmol/L
• This is below the diagnostic threshold of >2.5 nmol/L specified in guidelines 111
• This does not rule out PCOS—the patient may have the non-hyperandrogenic phenotype (Rotterdam Phenotype D: ovulatory dysfunction + polycystic ovaries without biochemical hyperandrogenism) 45

Progesterone Level

• Your patient's value: 1.5 nmol/L
• This is significantly below the 6 nmol/L threshold for normal ovulation 111
• This strongly indicates anovulation, a core feature of PCOS 11
• Low mid-luteal progesterone is a common finding in PCOS and supports the diagnosis 1

Insulin Level

• Your patient's value: 33 U/mL (assuming this is μU/mL, as U/mL is non-standard)
• This is markedly elevated and suggests insulin resistance 11
• Guidelines indicate glucose/insulin ratio >4 suggests reduced insulin sensitivity associated with PCOS 11
• Without a concurrent fasting glucose value, the full assessment is incomplete, but isolated hyperinsulinemia strongly suggests insulin resistance commonly seen in PCOS 11

Estradiol

• Your patient's value: 272 pmol/L (approximately 74 pg/mL)
• This is within normal follicular phase range
• Not diagnostically significant for or against PCOS 67

Prolactin

• Value not provided in your results
• Should be measured to exclude hyperprolactinemia (>20 μg/L abnormal) as an alternative diagnosis 111

Critical Next Steps for Diagnosis

PCOS requires meeting 2 of 3 Rotterdam criteria 45:

1. Oligo/anovulation - Your patient's progesterone <6 nmol/L confirms this ✓
2. Clinical or biochemical hyperandrogenism - Testosterone 2.4 nmol/L is borderline; assess clinical signs (hirsutism using Ferriman-Gallwey score, acne, androgenic alopecia) 18
3. Polycystic ovarian morphology - Requires ultrasound showing >10 peripheral cysts (2-8mm) or ovarian volume >10 cm³ 111, OR AMH >7.2 ng/mL as an alternative 443

What You Must Do Now:

• Obtain fasting glucose to calculate glucose/insulin ratio and assess for diabetes (fasting glucose >7.8 mmol/L abnormal) 11
• Measure prolactin to exclude hyperprolactinemia 11
• Perform pelvic ultrasound (transvaginal preferred) on days 3-9 of cycle, or measure AMH level (>7.2 ng/mL diagnostic) 443
• Assess clinical hyperandrogenism: Document hirsutism (Ferriman-Gallwey score), acne, androgenic alopecia 18
• Document menstrual pattern: Oligomenorrhea or amenorrhea confirms ovulatory dysfunction 45

Important Caveats

• Do not use ultrasound if within 8 years of menarche—multi-follicular ovaries are normal in adolescents 445
• Laboratory variability is significant—ensure your lab provides accurate, sensitive testosterone assays with appropriate female reference ranges 8
• Exclude other causes: thyroid dysfunction, non-classic congenital adrenal hyperplasia (measure 17-OH progesterone, DHEAS), Cushing's syndrome, androgen-secreting tumors 11
• The non-hyperandrogenic PCOS phenotype (Phenotype D) exists and carries metabolic risks despite normal testosterone 42

Your patient's profile—with anovulation (low progesterone), borderline LH/FSH ratio, and marked hyperinsulinemia—is highly suggestive of PCOS, but formal diagnosis requires completing the evaluation outlined above to meet Rotterdam criteria and exclude alternative diagnoses.